应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BSX 波士顿科学
交易中 06-09 13:21:16 EDT
49.25
+0.55
+1.12%
最高
49.86
最低
48.67
成交量
846.49万
今开
48.76
昨收
48.70
日振幅
2.44%
总市值
730.03亿
流通市值
727.58亿
总股本
14.82亿
成交额
4.17亿
换手率
0.57%
流通股本
14.77亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Truist下调波士顿科学目标价至64美元
中金财经 · 06-05
Truist下调波士顿科学目标价至64美元
异动解读|波士顿科学盘中上涨3.17%,医疗器械板块集体走强叠加分析师维持买入信号
行情直击 · 06-04
异动解读|波士顿科学盘中上涨3.17%,医疗器械板块集体走强叠加分析师维持买入信号
巴克莱下调波士顿科学目标价至89美元
中金财经 · 05-29
巴克莱下调波士顿科学目标价至89美元
异动解读|波士顿科学盘中下跌3.28%,多家投行下调目标价叠加CEO警示短期挑战
行情直击 · 05-28
异动解读|波士顿科学盘中下跌3.28%,多家投行下调目标价叠加CEO警示短期挑战
异动解读|波士顿科学盘中下跌8.13%,高盛下调目标价叠加FDA召回事件
行情直击 · 05-27
异动解读|波士顿科学盘中下跌8.13%,高盛下调目标价叠加FDA召回事件
异动解读|波士顿科学盘前下跌3.11%,高盛下调目标价至81美元
行情直击 · 05-27
异动解读|波士顿科学盘前下跌3.11%,高盛下调目标价至81美元
波士顿科学Seismiq™ 4Ce冠脉血管内碎石导管Fracture Ide试验达成主要安全性与有效性终点
美股速递 · 05-19
波士顿科学Seismiq™ 4Ce冠脉血管内碎石导管Fracture Ide试验达成主要安全性与有效性终点
FDA:波士顿科学公司将更新召回的起搏器
环球市场播报 · 05-08
FDA:波士顿科学公司将更新召回的起搏器
异动解读 | 波士顿科学盘中大跌5.02%,前一交易日大涨后获利回吐引发技术性调整
异动解读 · 04-25
异动解读 | 波士顿科学盘中大跌5.02%,前一交易日大涨后获利回吐引发技术性调整
【券商聚焦】中金国际上调波士顿科学(BSX)目标价至85美元 看好多元化增长前景
金吾财讯 · 04-23
【券商聚焦】中金国际上调波士顿科学(BSX)目标价至85美元 看好多元化增长前景
波士顿科学下调业绩指引股价反涨 市场看好其保守目标
投资观察 · 04-23
波士顿科学下调业绩指引股价反涨 市场看好其保守目标
异动解读 | 重申战略并购优先与财报亮眼,波士顿科学盘中大涨8.84%
异动解读 · 04-22
异动解读 | 重申战略并购优先与财报亮眼,波士顿科学盘中大涨8.84%
波士顿科学净利润大幅增长
环球市场播报 · 04-22
波士顿科学净利润大幅增长
异动解读 | 重申战略并购优先资本配置,波士顿科学盘前大涨5.17%
异动解读 · 04-22
异动解读 | 重申战略并购优先资本配置,波士顿科学盘前大涨5.17%
波士顿科学高管称下调2026年预测是"正确决策,最贴合当前市场环境"
美股速递 · 04-22
波士顿科学高管称下调2026年预测是"正确决策,最贴合当前市场环境"
波士顿科学高管重申:战略补强型并购仍为资本配置首要任务 股票回购次之
美股速递 · 04-22
波士顿科学高管重申:战略补强型并购仍为资本配置首要任务 股票回购次之
财报前瞻|波士顿科学本季营收预计增13.09%,机构多数看多
财报Agent · 04-15
财报前瞻|波士顿科学本季营收预计增13.09%,机构多数看多
波士顿科学对Accolade和Visionist起搏器启动产品校正与发布产品警示
美股速递 · 04-01
波士顿科学对Accolade和Visionist起搏器启动产品校正与发布产品警示
杰富瑞下调波士顿科学目标价至110美元
中金财经 · 03-31
杰富瑞下调波士顿科学目标价至110美元
波士顿科学面临增长放缓趋势——市场快讯
投资观察 · 03-30
波士顿科学面临增长放缓趋势——市场快讯
加载更多
公司概况
公司名称:
波士顿科学
所属市场:
NYSE
上市日期:
--
主营业务:
波士顿科学国际有限公司成立于1979年。该公司是医疗器械的全球开发商,制造商和销售商,这些医疗器械被广泛用于介入性医疗专业。该公司的内窥镜业务开发和制造用于诊断和治疗侵入性和微创技术的设备,以诊断和治疗广泛的胃肠道和肺部疾病。泌尿外科和盆腔健康业务开发和制造用于治疗各种泌尿和盆腔疾病的设备男性和女性解剖结构,包括肾结石,良性前列腺增生(BPH),前列腺癌,勃起功能障碍,失禁,骨盆底障碍,异常子宫出血以及子宫肌瘤和息肉。该公司的心律管理(CRM)业务开发和制造各种植入式设备,这些设备可监测心脏并输送电力以治疗心脏异常。该公司的电生理业务开发和制造用于诊断和治疗心脏的速率和节律紊乱的微创医疗技术,包括广泛的治疗和诊断导管产品以及电生理实验室中使用的各种设备。该公司的Neuromodulation业务开发和制造用于治疗各种神经系统运动障碍和管理慢性疼痛的设备。该公司的介入心脏病学业务开发,制造和商业化用于诊断和治疗冠状动脉疾病和其他心血管疾病(包括结构性心脏病)的技术。
发行价格:
--
{"stockData":{"symbol":"BSX","market":"US","secType":"STK","nameCN":"波士顿科学","latestPrice":49.245,"timestamp":1781025675792,"preClose":48.7,"halted":0,"volume":8464888,"delay":0,"changeRate":0.011190965092402352,"floatShares":1477475891,"shares":1482442039,"eps":2.389963,"marketStatus":"交易中","change":0.545,"latestTime":"06-09 13:21:16 EDT","open":48.76,"high":49.86,"low":48.67,"amount":416795340.42832,"amplitude":0.024435,"askPrice":49.25,"askSize":216,"bidPrice":49.24,"bidSize":725,"shortable":3,"etf":0,"ttmEps":2.389963,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781035200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":48.7,"preHourTrading":{"tag":"盘前","latestPrice":48.76,"preClose":48.7,"latestTime":"09:29 EDT","volume":8387,"amount":409451.54518200003,"timestamp":1781011799999,"change":0.06,"changeRate":0.001232,"amplitude":0.026899},"postHourTrading":{"tag":"盘后","latestPrice":48.73,"preClose":48.7,"latestTime":"19:59 EDT","volume":555378,"amount":27046874.0777,"timestamp":1780963172010,"change":0.03,"changeRate":0.000616,"amplitude":0.004517},"volumeRatio":0.679124,"impliedVol":0.3743,"impliedVolPercentile":0.8048},"requestUrl":"/m/hq/s/BSX","defaultTab":"news","newsList":[{"id":"2641863194","title":"Truist下调波士顿科学目标价至64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641863194","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641863194?lang=zh_cn&edition=full","pubTime":"2026-06-05 11:37","pubTimestamp":1780630623,"startTime":"0","endTime":"0","summary":"Truist将波士顿科学的目标价从85美元下调至64美元,维持“买入”评级。(格隆汇)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260605/32271020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BSX","UDN","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162003932","title":"异动解读|波士顿科学盘中上涨3.17%,医疗器械板块集体走强叠加分析师维持买入信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1162003932","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162003932?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:26","pubTimestamp":1780583214,"startTime":"0","endTime":"0","summary":"6月4日,波士顿科学盘中上涨3.17%,报49.27美元/股,成交额2.33亿美元。消息面上,尽管近期多家投行下调目标价,但均维持买入评级,加拿大皇家银行此前指出公司全年有机营收增长6.5%至8%的指引仍然完好,Watchman设备有望回归高增长轨道。Truist Securities虽将目标价从85美元下调至64美元,但维持买入评级,BTIG同样下调至65美元后维持买入。当日医疗保健设备板块集体走强,美敦力涨5.72%,雅培涨4.71%,直觉外科涨3.49%,板块联动效应明显。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639764223","title":"巴克莱下调波士顿科学目标价至89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2639764223","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639764223?lang=zh_cn&edition=full","pubTime":"2026-05-29 15:17","pubTimestamp":1780039023,"startTime":"0","endTime":"0","summary":"巴克莱将波士顿科学的目标价从96美元下调至89美元,维持“增持”评级。(格隆汇)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260529/32264294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["UUP","UDN","BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159212300","title":"异动解读|波士顿科学盘中下跌3.28%,多家投行下调目标价叠加CEO警示短期挑战","url":"https://stock-news.laohu8.com/highlight/detail?id=1159212300","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159212300?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:21","pubTimestamp":1779978087,"startTime":"0","endTime":"0","summary":"5月28日,波士顿科学盘中下跌3.28%,报48.805美元/股,成交额4.34亿美元,延续前一交易日跌势。此前高盛已将目标价从84美元下调至81美元,FDA披露的起搏器软件升级召回事件亦持续发酵。当前股价较52周高点109.50美元已回落逾55%,基本面方面,公司一季度营收52.03亿美元,同比增长11.58%,归母净利润13.41亿美元,同比增长98.96%。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104152973","title":"异动解读|波士顿科学盘中下跌8.13%,高盛下调目标价叠加FDA召回事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1104152973","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104152973?lang=zh_cn&edition=full","pubTime":"2026-05-27 21:40","pubTimestamp":1779889238,"startTime":"0","endTime":"0","summary":"5月27日,波士顿科学盘中下跌8.13%,报51.97美元/股,成交额3.52亿美元。消息面上,高盛将波士顿科学目标价从84美元下调至81美元,维持买入评级,据FactSet统计,该股当前分析师平均目标价为83.63美元。此外,FDA近期披露波士顿科学将对部分起搏器进行软件升级召回,对市场情绪形成压制。当前股价距52周高点109.50美元已回落逾52%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181406948","title":"异动解读|波士顿科学盘前下跌3.11%,高盛下调目标价至81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181406948","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181406948?lang=zh_cn&edition=full","pubTime":"2026-05-27 20:51","pubTimestamp":1779886289,"startTime":"0","endTime":"0","summary":"5月27日,波士顿科学盘前下跌3.11%,报55.83美元/股,成交额149.86万美元。消息面上,高盛将波士顿科学目标价从84美元下调至81美元,维持买入评级。据FactSet统计,该股当前分析师平均目标价为83.63美元。此外,FDA近期披露波士顿科学将对部分起搏器进行软件升级召回,或对市场情绪形成一定压制。基本面方面,公司一季度每股收益0.90美元,归母净利润13.41亿美元,同比增长98.96%,营收52.03亿美元,同比增长11.58%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100137075","title":"波士顿科学Seismiq™ 4Ce冠脉血管内碎石导管Fracture Ide试验达成主要安全性与有效性终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1100137075","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100137075?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:33","pubTimestamp":1779186794,"startTime":"0","endTime":"0","summary":"波士顿科学公司旗下Seismiq™ 4Ce冠脉血管内碎石导管的Fracture Ide试验,已成功达成预设的主要安全性与有效性终点。该结果标志着这一创新器械在临床评估中取得了关键进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","SG9999013999.USD","LU1989764664.SGD","LU0950375773.USD","LU1718418525.SGD","LU2362541513.USD","SGXZ57979304.SGD","LU2087625088.SGD","LU2324357040.USD","LU0345769128.USD","LU0823417653.USD","LU2244417387.USD","LU1366192091.USD","LU1720051017.SGD","IE00BFTCPJ56.SGD","LU1989772840.SGD","IE00B4R5TH58.HKD","LU2506952170.USD","LU0138981039.USD","SG9999001176.SGD","IE00B2B36J28.USD","LU0077335932.USD","BK4082","LU1057294990.SGD","LU1153585028.USD","LU1989771016.USD","LU2491050071.SGD","BK4588","LU1989772923.USD","LU2242649171.HKD","LU2357305700.SGD","LU1989764748.USD","LU0048584097.USD","BK4585","LU0353189763.USD","BSX","LU0266013472.USD","LU0823417737.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","LU1023059063.AUD","LU0238689110.USD","LU0251132253.USD","LU1791710582.SGD","LU1983299246.USD","LU2506952097.USD","LU2112291526.USD","LU1804176565.USD","LU2506951958.HKD","LU2506951875.HKD","BK4581","IE00BJT1NW94.SGD","SG9999001176.USD","LU1720051108.HKD","LU1291159041.SGD","BK4504","LU2491050154.USD","LU2362540622.SGD","LU1791710400.SGD","LU0528227936.USD","LU1061106388.HKD","LU0353189680.USD","LU2265009873.SGD","LU2491049909.HKD","LU0267386448.USD","LU0432979614.USD","LU0187121727.USD","LU0225283273.USD","LU1548497426.USD","IE0002141913.USD","LU0122379950.USD","LU2362541273.HKD","LU0114720955.EUR","IE0009355771.USD","LU0345769631.USD","LU0011850046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633105479","title":"FDA:波士顿科学公司将更新召回的起搏器","url":"https://stock-news.laohu8.com/highlight/detail?id=2633105479","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633105479?lang=zh_cn&edition=full","pubTime":"2026-05-08 07:10","pubTimestamp":1778195400,"startTime":"0","endTime":"0","summary":"FDA称,波士顿科学公司已向受影响的客户发函,建议将其所有的Accolade起搏器和心脏再同步治疗起搏器升级至Brady SMR6软件。FDA称,波士顿科学公司还指出了一个潜在风险,即旧软件可能导致电压恢复状态延长,这或将导致部分患者出现电池状态卡住或诊断问题。FDA称,截至3月18日,波士顿科学公司已报告了与该问题相关的四起死亡事件和2,557起严重伤害事件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-08/doc-inhxcqkr7869582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0432979614.USD","LU1791710582.SGD","LU2491050071.SGD","LU2506952170.USD","LU2506951875.HKD","LU1989772923.USD","LU0251132253.USD","LU0122379950.USD","LU0011850046.USD","LU0267386448.USD","LU0823417653.USD","LU2087625088.SGD","LU0187121727.USD","LU2491050154.USD","LU0823417737.USD","SGXZ57979304.SGD","LU2362540622.SGD","SG9999001176.SGD","BK4082","LU1989764664.SGD","LU1291159041.SGD","LU1983299246.USD","IE00B2B36J28.USD","LU0266013472.USD","LU1548497426.USD","LU1720051017.SGD","LABU","LU2324357040.USD","LU0353189763.USD","BSX","IE00BJJMRZ35.SGD","LU0138981039.USD","BK4585","LU0882574055.USD","LU1804176565.USD","LU2362541513.USD","SG9999001176.USD","LU0950375773.USD","IE0009355771.USD","LU1718418525.SGD","LU1989764748.USD","LU0345769631.USD","LU1023059063.AUD","LU0823416689.USD","LU1061106388.HKD","LU2491049909.HKD","LU2357305700.SGD","BK4581","LU0048584097.USD","LU2265009873.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174359326","title":"异动解读 | 波士顿科学盘中大跌5.02%,前一交易日大涨后获利回吐引发技术性调整","url":"https://stock-news.laohu8.com/highlight/detail?id=1174359326","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174359326?lang=zh_cn&edition=full","pubTime":"2026-04-25 00:23","pubTimestamp":1777047796,"startTime":"0","endTime":"0","summary":"波士顿科学(BSX)今日盘中股价大跌5.02%,引起了市场的关注。消息面上,波士顿科学此前公布的一季度业绩超出市场预期,但公司同时下调了全年调整后每股收益预期,市场将此视为业绩重置,预留了未来超预期的空间,推动其股价在前一交易日大幅上涨。今日的下跌,主要被解读为短线获利资金了结所致的技术性调整。中金国际此前上调了波士顿科学的目标价,并维持“跑赢行业”评级。当前股价回落,反映了市场在短期快速上涨后的正常波动和获利了结行为。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629887146","title":"【券商聚焦】中金国际上调波士顿科学(BSX)目标价至85美元 看好多元化增长前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2629887146","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629887146?lang=zh_cn&edition=full","pubTime":"2026-04-23 18:06","pubTimestamp":1776938787,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中金国际发研报指出,波士顿科学 第一季度业绩符合预期,收入达到52.03亿美元,同比增长12%;经调整EPS为0.80美元,去年同期为0.75美元。该行表示,尽管电生理业务面临竞争加剧,但波士顿科学凭借多元化的产品线和市场策略,有望步入多元化增长的新常态。尽管面临竞争格局恶化、新品推广不及预期、研发失败和集采影响等风险,该行维持对波士顿科学的“跑赢行业”评级。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NjViMmRjZjhjOGM5NGFlMzkzMTgwODQxMTc3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjViMmRjZjhjOGM5NGFlMzkzMTgwODQxMTc3.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299601","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UUP","UDN","BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116061193","title":"波士顿科学下调业绩指引股价反涨 市场看好其保守目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1116061193","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116061193?lang=zh_cn&edition=full","pubTime":"2026-04-23 03:04","pubTimestamp":1776884669,"startTime":"0","endTime":"0","summary":"医疗设备制造商波士顿科学周三大幅下调2026年度营收预期,归因于肾结石治疗设备和Watchman心脏节律设备等业务的销售表现不及预期。然而该公司股价周三飙升8%,有望创下2020年3月以来最大单日涨幅。市场反应显示投资者早已预期业绩指引会下调,而修订后的较低目标如今显得更具可实现性。周三公布的修正方案将增长目标降至最高8.5%。分析师认为新指引相当于一次业绩重置,其保守特性反而为波士顿科学预留了超预期发挥的空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1791710400.SGD","LU1720051108.HKD","LU2244417387.USD","LU0138981039.USD","LU1548497426.USD","LU2506951875.HKD","SG9999001176.SGD","LU2506952097.USD","LU0114720955.EUR","LU0251132253.USD","LU1804176565.USD","LU0225283273.USD","LU1291159041.SGD","LU2112291526.USD","LU0122379950.USD","LU0266013472.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1983299246.USD","LU1366192091.USD","BK4504","LU0238689110.USD","LU1153585028.USD","BK4082","LU1791710582.SGD","LU2362540622.SGD","SG9999013999.USD","LU0267386448.USD","LU0345769631.USD","BK4581","LU2087625088.SGD","LU0823416689.USD","LU0048584097.USD","LU0823417653.USD","LU0011850046.USD","LU0077335932.USD","LU0950375773.USD","LU1989771016.USD","LU0353189680.USD","LU2362541513.USD","LU0882574055.USD","IE00BFTCPJ56.SGD","LU1989764748.USD","LU2506952170.USD","SGXZ57979304.SGD","SG9999001176.USD","BSX","LU1061106388.HKD","LU2357305700.SGD","LU2491050154.USD","BK4588","IE0002141913.USD","LU2242649171.HKD","LU2362541273.HKD","IE0009355771.USD","LU0187121727.USD","LU1718418525.SGD","LU1989772840.SGD","LU0432979614.USD","LU0528227936.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2491049909.HKD","IE00BJT1NW94.SGD","LU1989772923.USD","LU2491050071.SGD","LU1057294990.SGD","LU1720051017.SGD","LU2324357040.USD","LU0353189763.USD","LU2506951958.HKD","LU0823417737.USD","LU1989764664.SGD","LU0345769128.USD","LU2265009873.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167140988","title":"异动解读 | 重申战略并购优先与财报亮眼,波士顿科学盘中大涨8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167140988","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167140988?lang=zh_cn&edition=full","pubTime":"2026-04-22 21:57","pubTimestamp":1776866234,"startTime":"0","endTime":"0","summary":"波士顿科学(BSX)今日盘中股价大幅上涨8.84%,引起了市场的广泛关注。消息面上,公司高管近期重申了其资本配置的优先顺序,将战略性的补强型并购交易置于首位,股份回购计划次之。这一表态凸显了公司致力于通过精准收购来强化产品组合与技术平台的战略导向,展现出对长期增长潜力的侧重,增强了投资者对公司未来竞争力的信心。此外,公司公布的第一季度财报显示净利润近乎翻倍,销售额增长12%,其中心血管设备销售额增长显著。尽管公司同时略微下调了全年调整后每股收益预期,但强劲的季度业绩表现和明确的增长战略共同推动了股价的积极反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629906044","title":"波士顿科学净利润大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2629906044","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629906044?lang=zh_cn&edition=full","pubTime":"2026-04-22 21:10","pubTimestamp":1776863400,"startTime":"0","endTime":"0","summary":" 波士顿科学将 2026 年调整后每股收益预期从此前预估下调至 3.34 美元至 3.41 美元。 波士顿科学表示,受全球范围内其支架、导管及其他心血管设备需求持续增长推动,公司一季度净利润近乎翻倍,但同时下调了本年度调整后收益增长预期。 销售额增长 12% 至 52 亿美元,超出 FactSet 统计的分析师平均预期 51.7 亿美元。 该支架制造商预计,二季度调整后每股收益在 82 美分至 84 美分之间,销售额增速为 5.5% 至 7.5%。波士顿科学预计有机销售额增速为 6.5% 至 8%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-22/doc-inhvkupu5488730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162861106","title":"异动解读 | 重申战略并购优先资本配置,波士顿科学盘前大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162861106","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162861106?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:43","pubTimestamp":1776861798,"startTime":"0","endTime":"0","summary":"波士顿科学今日盘前股价大幅上涨5.17%,引起了市场的广泛关注。消息面上,公司高管近期重申了其资本配置的优先顺序,将战略性的补强型并购交易置于首位,股份回购计划次之。这一表态凸显了公司致力于通过精准收购来强化产品组合与技术平台的战略导向,展现出对长期增长潜力的侧重,增强了投资者对公司未来竞争力的信心。分析认为,相较于大规模股票回购,公司更倾向于将资金投入能够直接增强核心业务的中小型并购项目,以快速获取关键技术或填补产品线空白,从而在竞争激烈的医疗器械领域保持领先地位。这种审慎且着眼于外延扩张的资本管理策略获得了市场的积极回应。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147131107","title":"波士顿科学高管称下调2026年预测是\"正确决策,最贴合当前市场环境\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1147131107","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147131107?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:37","pubTimestamp":1776861443,"startTime":"0","endTime":"0","summary":"波士顿科学公司高管近日就下调2026年业绩预测一事作出回应,强调这一调整是\"顺应时势的正确决策\",最能准确反映当前的市场环境变化。\n该公司管理层表示,基于对宏观经济形势和行业动态的全面评估,修正长期展望是保持财务透明度的重要举措。这一调整既体现了管理层对股东负责的态度,也展现了公司应对市场变化的务实策略。\n在复杂多变的医疗设备行业背景下,波士顿科学主动调整预期目标,显示出其灵活应变的能力和对市场趋势的敏锐把握。公司强调将继续专注于创新研发和市场拓展,为长期可持续发展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1804176565.USD","BK4082","LU0882574055.USD","LU2324357040.USD","LU1989764664.SGD","LU0353189680.USD","IE0002141913.USD","LU0011850046.USD","LU1989771016.USD","LU1791710400.SGD","IE00BJT1NW94.SGD","BK4581","SG9999013999.USD","IE00BFTCPJ56.SGD","LU1718418525.SGD","LU0432979614.USD","LU1983299246.USD","LU2244417387.USD","LU0823416689.USD","LU2491049909.HKD","LU0122379950.USD","LU0823417737.USD","LU2362541273.HKD","LU0950375773.USD","LU1989772840.SGD","SG9999001176.USD","LU2357305700.SGD","LU0823417653.USD","SGXZ57979304.SGD","LU2506951958.HKD","LU1989764748.USD","LU0345769631.USD","LU1153585028.USD","IE00BJJMRZ35.SGD","LU0266013472.USD","LU2506952170.USD","IE0009355771.USD","LU2087625088.SGD","LU2491050154.USD","LU1791710582.SGD","IE00B4R5TH58.HKD","LU2242649171.HKD","LU0077335932.USD","LU1989772923.USD","LU2112291526.USD","SG9999001176.SGD","LU0251132253.USD","LU1023059063.AUD","LU1720051108.HKD","BK4588","LU0528227936.USD","LU1057294990.SGD","LU1291159041.SGD","LU2506951875.HKD","LU0114720955.EUR","LU1548497426.USD","LU0238689110.USD","LU2506952097.USD","LU0138981039.USD","LU0187121727.USD","BSX","BK4504","LU2362540622.SGD","LU0225283273.USD","LU1366192091.USD","LU2362541513.USD","LU1720051017.SGD","LU0345769128.USD","LU1061106388.HKD","LU2491050071.SGD","LU0267386448.USD","IE00B2B36J28.USD","LU2265009873.SGD","LU0048584097.USD","LU0353189763.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133659751","title":"波士顿科学高管重申:战略补强型并购仍为资本配置首要任务 股票回购次之","url":"https://stock-news.laohu8.com/highlight/detail?id=1133659751","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133659751?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:25","pubTimestamp":1776860723,"startTime":"0","endTime":"0","summary":"波士顿科学公司高管近日明确表示,公司资本配置的优先顺序保持不变:战略性的补强型并购交易仍位居首位,随后才是股份回购计划。这一表态凸显了该医疗科技巨头持续通过精准收购来强化产品组合与技术平台的战略导向。在资本分配策略上,波士顿科学展现出对长期增长而非短期股东回报的侧重。股份回购作为资本配置的次要选项,主要起到平衡资本结构、优化每股收益的作用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1153585028.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU1548497426.USD","LU2087625088.SGD","LU2242649171.HKD","LU0225283273.USD","LU0882574055.USD","BK4504","SG9999001176.SGD","LU0138981039.USD","BK4581","LU2506951958.HKD","SG9999001176.USD","LU0187121727.USD","LU0950375773.USD","LU1989772840.SGD","LU2362541273.HKD","LU0238689110.USD","LU2112291526.USD","LU0077335932.USD","LU1989772923.USD","LU0267386448.USD","LU1023059063.AUD","IE0002141913.USD","IE0009355771.USD","LU0528227936.USD","LU2244417387.USD","LU0345769631.USD","LU1791710582.SGD","LU2491050071.SGD","LU0823416689.USD","LU0823417653.USD","LU2491050154.USD","BK4082","IE00B2B36J28.USD","LU0114720955.EUR","LU1291159041.SGD","IE00BJT1NW94.SGD","LU1718418525.SGD","LU1720051108.HKD","LU1804176565.USD","LU1057294990.SGD","LU0048584097.USD","IE00B4R5TH58.HKD","BK4588","LU0266013472.USD","LU0353189680.USD","LU1791710400.SGD","LU2324357040.USD","LU2506951875.HKD","LU1366192091.USD","LU0122379950.USD","LU0011850046.USD","LU2506952170.USD","LU0432979614.USD","LU1989764664.SGD","SG9999013999.USD","LU2357305700.SGD","LU0251132253.USD","LU2506952097.USD","BK4585","LU1720051017.SGD","LU1989764748.USD","LU0823417737.USD","LU2265009873.SGD","LU2362541513.USD","BSX","LU1061106388.HKD","LU2491049909.HKD","LU2362540622.SGD","LU1989771016.USD","LU0345769128.USD","LU0353189763.USD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134458033","title":"财报前瞻|波士顿科学本季营收预计增13.09%,机构多数看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1134458033","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134458033?lang=zh_cn&edition=full","pubTime":"2026-04-15 08:22","pubTimestamp":1776212530,"startTime":"0","endTime":"0","summary":"波士顿科学将于2026年04月22日美股盘前发布最新季度财报,市场聚焦收入与每股收益的同比增长持续性及核心产品动能。公司主营业务以心血管器械为主,上季度口径占比66.01%,实现收入132.50亿美元,结构性心脏病与电生理产品组合驱动高景气度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|波士顿科学本季营收预计增13.09%,机构多数看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1172754606","title":"波士顿科学对Accolade和Visionist起搏器启动产品校正与发布产品警示","url":"https://stock-news.laohu8.com/highlight/detail?id=1172754606","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172754606?lang=zh_cn&edition=full","pubTime":"2026-04-01 07:09","pubTimestamp":1774998552,"startTime":"0","endTime":"0","summary":"澳大利亚治疗用品管理局发布通告,医疗科技企业波士顿科学(Boston Scientific)正针对其Accolade与Visionist系列心脏起搏器开展产品校正行动,并同步发布产品安全警示。此次行动涉及特定批次的设备,公司已启动主动监测与更换流程,以确保患者安全。监管部门建议临床医生核查受影响设备序列号,并及时与厂商沟通后续处理方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU1791710400.SGD","LU1791710582.SGD","LU2506951875.HKD","LU2491050071.SGD","LU2506952170.USD","LU1057294990.SGD","LU2244417387.USD","LU2362541273.HKD","LU1989772923.USD","LU0251132253.USD","IE0002141913.USD","LU0011850046.USD","LU0122379950.USD","LU0267386448.USD","LU0823417653.USD","LU0187121727.USD","LU2087625088.SGD","LU2491050154.USD","LU0823417737.USD","SGXZ57979304.SGD","LU2362540622.SGD","SG9999001176.SGD","BK4082","LU1989764664.SGD","LU1291159041.SGD","LU0353189680.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU1989771016.USD","IE00B2B36J28.USD","LU0266013472.USD","LU1548497426.USD","LU2242649171.HKD","BK4588","LU1720051017.SGD","LU1720051108.HKD","LU2324357040.USD","LU0114720955.EUR","BSX","IE00BJJMRZ35.SGD","LU0353189763.USD","LU2506951958.HKD","SG9999013999.USD","LU0238689110.USD","LU1153585028.USD","BK4585","IE00BJT1NW94.SGD","BK4504","LU1989772840.SGD","LU2112291526.USD","LU2506952097.USD","LU0882574055.USD","LU1804176565.USD","LU2362541513.USD","SG9999001176.USD","LU0950375773.USD","IE0009355771.USD","LU1718418525.SGD","LU1989764748.USD","LU0345769631.USD","LU1023059063.AUD","LU0823416689.USD","LU0077335932.USD","LU0528227936.USD","LU1061106388.HKD","LU0345769128.USD","IE00B4R5TH58.HKD","LU2491049909.HKD","LU2357305700.SGD","BK4581","LU0225283273.USD","LU0048584097.USD","LU2265009873.SGD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623374972","title":"杰富瑞下调波士顿科学目标价至110美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623374972","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623374972?lang=zh_cn&edition=full","pubTime":"2026-03-31 11:37","pubTimestamp":1774928221,"startTime":"0","endTime":"0","summary":"杰富瑞将波士顿科学的目标价从120美元下调至110美元,维持“买入”评级。(格隆汇)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260331/32115210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["UDN","UUP","BSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147095452","title":"波士顿科学面临增长放缓趋势——市场快讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1147095452","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147095452?lang=zh_cn&edition=full","pubTime":"2026-03-30 23:36","pubTimestamp":1774884995,"startTime":"0","endTime":"0","summary":"雷蒙德·詹姆斯公司宣布将波士顿科学的评级从“强力买入”下调至“跑赢大盘”。尽管该股仍是医疗科技领域的优选标的,但分析师指出其电生理业务和针对房颤患者的Watchman解决方案产品线正显现增长放缓迹象。\n分析师杰森·贝德福德表示,虽然公司Watchman设备CHAMPION-AF试验结果积极,但占2025年总销售额26%的Watchman与电生理业务增长隐忧正在削弱市场热情。他强调:“需要明确的是,股价疲软已基本反映这一担忧,因此我们仍对该股持乐观态度。”\n当日波士顿科学股价下跌9.5%至62.63美元,创下2024年初以来新低。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051108.HKD","LU0187121727.USD","LU2112291526.USD","LU0353189680.USD","LU1989772840.SGD","LU1989771016.USD","BK4082","LU0238689110.USD","LU0353189763.USD","LU1989772923.USD","LU2362540622.SGD","LU0011850046.USD","LU2506951958.HKD","SG9999013999.USD","LU0882574055.USD","IE00BFTCPJ56.SGD","LU0345769128.USD","SG9999001176.USD","LU1720051017.SGD","LU2242649171.HKD","BK4581","LU0048584097.USD","LU2491050154.USD","LU0077335932.USD","LU1718418525.SGD","SGXZ57979304.SGD","LU0251132253.USD","IE0009355771.USD","LU1983299246.USD","LU1989764748.USD","LU0267386448.USD","BSX","LU2265009873.SGD","LU2506951875.HKD","LU0225283273.USD","IE0002141913.USD","BK4588","LU0528227936.USD","LU0823417653.USD","LU2244417387.USD","LU2506952097.USD","LU2357305700.SGD","SG9999001176.SGD","LU0432979614.USD","LU1291159041.SGD","IE00B4R5TH58.HKD","LU1057294990.SGD","BK4504","IE00BJT1NW94.SGD","LU0266013472.USD","LU1153585028.USD","LU2362541273.HKD","LU1791710582.SGD","LU0345769631.USD","IE00BJJMRZ35.SGD","LU1989764664.SGD","LU2362541513.USD","LU2491049909.HKD","LU0823417737.USD","LU2491050071.SGD","LU1791710400.SGD","BK4585","IE00B2B36J28.USD","LU1804176565.USD","LU2506952170.USD","LU0114720955.EUR","LU0950375773.USD","LU0823416689.USD","LU1023059063.AUD","LU1366192091.USD","LU2324357040.USD","LU1548497426.USD","LU2087625088.SGD","LU0122379950.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bostonscientific.com","stockEarnings":[{"period":"1week","weight":0.015},{"period":"1month","weight":-0.097},{"period":"3month","weight":-0.3039},{"period":"6month","weight":-0.4746},{"period":"1year","weight":-0.523},{"period":"ytd","weight":-0.4893}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":0.0022},{"period":"3month","weight":0.0916},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.2338},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"波士顿科学国际有限公司成立于1979年。该公司是医疗器械的全球开发商,制造商和销售商,这些医疗器械被广泛用于介入性医疗专业。该公司的内窥镜业务开发和制造用于诊断和治疗侵入性和微创技术的设备,以诊断和治疗广泛的胃肠道和肺部疾病。泌尿外科和盆腔健康业务开发和制造用于治疗各种泌尿和盆腔疾病的设备男性和女性解剖结构,包括肾结石,良性前列腺增生(BPH),前列腺癌,勃起功能障碍,失禁,骨盆底障碍,异常子宫出血以及子宫肌瘤和息肉。该公司的心律管理(CRM)业务开发和制造各种植入式设备,这些设备可监测心脏并输送电力以治疗心脏异常。该公司的电生理业务开发和制造用于诊断和治疗心脏的速率和节律紊乱的微创医疗技术,包括广泛的治疗和诊断导管产品以及电生理实验室中使用的各种设备。该公司的Neuromodulation业务开发和制造用于治疗各种神经系统运动障碍和管理慢性疼痛的设备。该公司的介入心脏病学业务开发,制造和商业化用于诊断和治疗冠状动脉疾病和其他心血管疾病(包括结构性心脏病)的技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.617647,"avgChangeRate":0.051947},{"month":2,"riseRate":0.529412,"avgChangeRate":-0.001374},{"month":3,"riseRate":0.558824,"avgChangeRate":0.019363},{"month":4,"riseRate":0.647059,"avgChangeRate":0.01572},{"month":5,"riseRate":0.588235,"avgChangeRate":0.015117},{"month":6,"riseRate":0.514286,"avgChangeRate":0.005011},{"month":7,"riseRate":0.617647,"avgChangeRate":0.019016},{"month":8,"riseRate":0.441176,"avgChangeRate":0.003398},{"month":9,"riseRate":0.382353,"avgChangeRate":-0.02534},{"month":10,"riseRate":0.470588,"avgChangeRate":0.00099},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.01032},{"month":12,"riseRate":0.764706,"avgChangeRate":0.036197}],"exchange":"NYSE","name":"波士顿科学","nameEN":"Boston Scientific"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"波士顿科学(BSX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供波士顿科学(BSX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"波士顿科学,BSX,波士顿科学股票,波士顿科学股票老虎,波士顿科学股票老虎国际,波士顿科学行情,波士顿科学股票行情,波士顿科学股价,波士顿科学股市,波士顿科学股票价格,波士顿科学股票交易,波士顿科学股票购买,波士顿科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"波士顿科学(BSX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供波士顿科学(BSX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}